Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-14

Clinical Trial Update: The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial examining the effects of insulin detemir and gliclazide-MR on endothelial function in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gliclazide MR (gliclazide MR)
  • Insulin detemir (insulin detemir)

Snippet

Sponsor: Ankara University | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED